Commencement of exercise period for the Warrants
Summary by AI BETAClose X
NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
Oslo, Norway, 26 May 2026 – Circio Holding ASA (OSE: CRNA) (“Circio” or the “Company”), a biotechnology company developing novel circular RNA expression technology for gene and cell therapy, announces the commencement of the exercise period for the 67,680,945 warrants issued on ISIN NO0013711523 in connection with the rights issue and related private placement (Nw.: frittstående tegningsretter) (the “Warrants”).
The exercise window for the Warrants opens today, 26 May 2026, at 08:00 CEST. The Warrants can be exercised digitally through the systems of VPS, which are available from the websites of Pareto Securities AS (www.paretosec.com/transactions) and Circio or by completion of an exercise form (the "Exercise Form") available at the websites of Pareto Securities AS and Circio. Only Norwegian personal shareholders are able to exercise Warrants digitally through the systems of VPS.
KEY TERMS AND DATES:
- Warrant exercise price: NOK 8.2508 per share (20% discount to VWAP 8–22 May 2026)
- Warrant exercise period: 26 May - 9 June 2026
- Warrant trading: The Warrants are listed and tradable on the Oslo Stock Exchange under the ticker code "CRNAS" with ISIN NO0013711523
- Warrant trading period: The Warrants are tradable up to and including 3 June 2026
- Unexercised Warrants: Warrants not exercised by the end of the exercise period will lapse without any compensation to the holder
- Notification of allocation: On or about 10 June 2026
- Warrant payment date: 12 June 2026
- Registration of share capital increase: On or about 18 June 2026
- First day of trading for the new shares: On or about 18 June 2026 (post completion of the share capital increase)
- Delivery of new shares: On or about 19 June 2026
MAIN ALTERNATIVES FOR WARRANT HOLDERS:
- Exercise currently held Warrants during the exercise period, pay the exercise price and receive new shares in Circio.
- Buy additional Warrants on the Oslo Stock Exchange. Subsequently exercise all held Warrants during the exercise period, pay the exercise price and receive new shares in Circio.
- Sell a portion of currently held Warrants during the trading period. Subsequently exercise the remaining Warrants held during the exercise period, pay the exercise price and receive shares in Circio.
- Sell all currently held Warrants during the trading period on the Oslo Stock Exchange.
- Do nothing. Warrants not exercised by 9 June 2026 will lapse without any compensation to the holder.
INFORMATION RELATED TO FINANCING OF WARRANTS:
Exercising Warrants means buying new shares in Circio at the Exercise Price of NOK 8.2508 per share. The aggregate exercise price must be settled in cash on the Warrant payment date (12 June 2026), and investors planning to exercise Warrants must secure sufficient financing ahead of that date. Illustrative example: A holder of 100,000 Warrants would need NOK 825,080 (100,000 × NOK 8.2508) to exercise all Warrants.
Q&A RELATED TO THE WARRANTS:
Please visit the websites of Pareto Securities: https://paretosec.no/investeringer/emisjoner/warranter-circio-holding
FURTHER INFORMATION ABOUT THE WARRANTS:
The grant or purchase of Warrants by persons resident in, or who are citizens of countries other than Norway or Sweden, may be affected by the laws of the relevant jurisdiction. For a further description of such restrictions, reference is made to Section 11 "Selling and Transfer Restrictions" in the securities note dated 13 January 2026 (the "Securities Note", and together with a registration document dated 1 October 2025, and a registration document supplement and summary dated 13 January 2026, comprise the "Prospectus").
For more information about the Warrants, please refer to the Prospectus. The Prospectus is available on the Company's website: https://www.circio.com/en/prospectus-for-the-rights-issue-2026/.
Latest directors dealings
- 2 hours ago Tertiary Minerals
- 2 hours ago Hargreaves Services
- 15 hours ago ASOS
- 16 hours ago MJ Gleeson
- 16 hours ago Rolls-Royce Holdings